IL141843A0 - Vaccine against sexually transmitted diseases - Google Patents

Vaccine against sexually transmitted diseases

Info

Publication number: IL141843A0
Authority: IL; Israel
Prior art keywords: vaccine against; sexually transmitted; transmitted diseases; against sexually; diseases
Prior art date: 1998-09-11

Application number

IL14184399A

Other languages

English (en)

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-11

Filing date

1999-09-08

Publication date

2002-03-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10838766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL141843(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-09-08 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2002-03-10 Publication of IL141843A0 publication Critical patent/IL141843A0/xx

Links

208000019802 Sexually transmitted disease Diseases 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

IL14184399A 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases IL141843A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9819898A GB9819898D0 (en)	1998-09-11	1998-09-11	New vaccine and method of use
PCT/EP1999/006623 WO2000015255A1 (en)	1998-09-11	1999-09-08	Vaccine against sexually transmitted diseases

Publications (1)

Publication Number	Publication Date
IL141843A0 true IL141843A0 (en)	2002-03-10

Family

ID=10838766

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14184399A IL141843A0 (en)	1998-09-11	1999-09-08	Vaccine against sexually transmitted diseases

Country Status (28)

Country	Link
EP (1)	EP1109574B1 (da)
JP (1)	JP2002524532A (da)
KR (1)	KR100777896B1 (da)
CN (2)	CN101130070A (da)
AR (1)	AR021798A1 (da)
AT (1)	ATE392214T1 (da)
AU (1)	AU744989B2 (da)
BR (1)	BR9913630A (da)
CA (1)	CA2343399C (da)
CO (1)	CO5090882A1 (da)
CY (1)	CY1108147T1 (da)
CZ (1)	CZ302808B6 (da)
DE (1)	DE69938555T2 (da)
DK (1)	DK1109574T3 (da)
ES (1)	ES2304068T3 (da)
GB (1)	GB9819898D0 (da)
HU (1)	HUP0104297A3 (da)
IL (1)	IL141843A0 (da)
MY (1)	MY122216A (da)
NO (1)	NO329522B1 (da)
NZ (1)	NZ510425A (da)
PL (1)	PL199545B1 (da)
PT (1)	PT1109574E (da)
SI (1)	SI1109574T1 (da)
TR (1)	TR200100948T2 (da)
TW (1)	TWI225790B (da)
WO (1)	WO2000015255A1 (da)
ZA (1)	ZA200101987B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU750587B2 (en)	1998-10-16	2002-07-25	Smithkline Beecham Biologicals (Sa)	Adjuvant systems and vaccines
GB9921146D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
AU2006335256B2 (en)	2005-11-22	2012-10-18	Novartis Vaccines And Diagnostics, Inc.	Norovirus and sapovirus antigens
EP1998800A2 (en)	2006-01-18	2008-12-10	University Of Chicago	Compositions and methods related to staphylococcal bacterium proteins
CA2699513C (en)	2007-09-12	2018-03-13	Novartis Ag	Gas57 mutant antigens and gas57 antibodies
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
EP2443250B8 (en)	2009-06-16	2016-09-21	GlaxoSmithKline Biologicals SA	High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
WO2011026111A1 (en)	2009-08-31	2011-03-03	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Oral delivery of a vaccine to the large intestine to induce mucosal immunity
ES2643498T3 (es)	2010-04-08	2017-11-23	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Ensayo de células presentadoras de antígenos de linfocitos B
CN102933267B (zh)	2010-05-28	2015-05-27	泰特里斯在线公司	交互式混合异步计算机游戏基础结构
EP2726097A4 (en)	2011-07-01	2015-03-11	Univ California	HERPES VIRUS VACCINE AND METHOD OF USE
US10052329B2 (en) *	2014-07-07	2018-08-21	Elian Llc	Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
US11071745B2 (en)	2014-07-07	2021-07-27	Elian Llc	Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
KR20180115276A (ko)	2016-02-22	2018-10-22	베링거잉겔하임베트메디카게엠베하	생체 분자의 고정화 방법
WO2020086408A1 (en)	2018-10-26	2020-04-30	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	A high-yield perfusion-based transient gene expression bioprocess

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9105992D0 (en) *	1991-03-21	1991-05-08	Smithkline Beecham Biolog	Vaccine
SG48309A1 (en) *	1993-03-23	1998-04-17	Smithkline Beecham Biolog	Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
GB9326253D0 (en) *	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
GB9506863D0 (en) *	1995-04-03	1995-05-24	Smithkline Beecham Biolog	Vaccines

1998
- 1998-09-11 GB GB9819898A patent/GB9819898D0/en not_active Ceased
1999
- 1999-09-08 TR TR200100948T patent/TR200100948T2/xx unknown
- 1999-09-08 PL PL346651A patent/PL199545B1/pl not_active IP Right Cessation
- 1999-09-08 CN CNA2007101469740A patent/CN101130070A/zh active Pending
- 1999-09-08 DK DK99969034T patent/DK1109574T3/da active
- 1999-09-08 AU AU59752/99A patent/AU744989B2/en not_active Ceased
- 1999-09-08 EP EP99969034A patent/EP1109574B1/en not_active Expired - Lifetime
- 1999-09-08 CA CA 2343399 patent/CA2343399C/en not_active Expired - Fee Related
- 1999-09-08 HU HU0104297A patent/HUP0104297A3/hu unknown
- 1999-09-08 PT PT99969034T patent/PT1109574E/pt unknown
- 1999-09-08 DE DE1999638555 patent/DE69938555T2/de not_active Expired - Lifetime
- 1999-09-08 SI SI9931008T patent/SI1109574T1/sl unknown
- 1999-09-08 KR KR1020017003161A patent/KR100777896B1/ko not_active Expired - Fee Related
- 1999-09-08 NZ NZ51042599A patent/NZ510425A/xx not_active IP Right Cessation
- 1999-09-08 IL IL14184399A patent/IL141843A0/xx not_active IP Right Cessation
- 1999-09-08 AT AT99969034T patent/ATE392214T1/de active
- 1999-09-08 CZ CZ20010887A patent/CZ302808B6/cs not_active IP Right Cessation
- 1999-09-08 WO PCT/EP1999/006623 patent/WO2000015255A1/en not_active Ceased
- 1999-09-08 BR BR9913630A patent/BR9913630A/pt not_active Application Discontinuation
- 1999-09-08 JP JP2000569839A patent/JP2002524532A/ja active Pending
- 1999-09-08 ES ES99969034T patent/ES2304068T3/es not_active Expired - Lifetime
- 1999-09-08 CN CN99813127A patent/CN1325311A/zh active Pending
- 1999-09-09 AR ARP990104534 patent/AR021798A1/es unknown
- 1999-09-09 MY MYPI99003916A patent/MY122216A/en unknown
- 1999-09-10 CO CO99057608A patent/CO5090882A1/es unknown
- 1999-09-14 TW TW88115828A patent/TWI225790B/zh not_active IP Right Cessation
2001
- 2001-03-08 NO NO20011193A patent/NO329522B1/no not_active IP Right Cessation
- 2001-03-09 ZA ZA200101987A patent/ZA200101987B/en unknown
2008
- 2008-06-18 CY CY081100643T patent/CY1108147T1/el unknown

Also Published As

Publication number	Publication date
NZ510425A (en)	2003-04-29
EP1109574A1 (en)	2001-06-27
AU5975299A (en)	2000-04-03
CN101130070A (zh)	2008-02-27
CN1325311A (zh)	2001-12-05
MY122216A (en)	2006-03-31
PL346651A1 (en)	2002-02-25
NO20011193D0 (no)	2001-03-08
HUP0104297A2 (hu)	2002-03-28
ATE392214T1 (de)	2008-05-15
TWI225790B (en)	2005-01-01
CA2343399C (en)	2010-08-03
HUP0104297A3 (en)	2004-10-28
WO2000015255A1 (en)	2000-03-23
NO329522B1 (no)	2010-11-01
GB9819898D0 (en)	1998-11-04
DE69938555D1 (de)	2008-05-29
NO20011193L (no)	2001-05-09
KR20010075049A (ko)	2001-08-09
SI1109574T1 (sl)	2008-08-31
CA2343399A1 (en)	2000-03-23
CZ302808B6 (cs)	2011-11-23
AR021798A1 (es)	2002-08-07
KR100777896B1 (ko)	2007-11-27
CY1108147T1 (el)	2014-02-12
HK1037978A1 (en)	2002-03-01
ES2304068T3 (es)	2008-09-01
JP2002524532A (ja)	2002-08-06
CZ2001887A3 (cs)	2001-10-17
BR9913630A (pt)	2001-05-22
ZA200101987B (en)	2002-05-09
CO5090882A1 (es)	2001-10-30
PL199545B1 (pl)	2008-09-30
DK1109574T3 (da)	2008-06-30
PT1109574E (pt)	2008-06-12
DE69938555T2 (de)	2009-06-10
EP1109574B1 (en)	2008-04-16
TR200100948T2 (tr)	2001-07-23
AU744989B2 (en)	2002-03-07

Legal Events

Date	Code	Title	Description
2006-08-01	FF	Patent granted
2014-04-30	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
IL137294A0 (en)	2001-07-24	Antibodies against human cd40
IL158107A0 (en)	2004-03-28	Human papillomaviruses vaccine
HUP0103976A3 (en)	2008-04-28	Novel methods for therapeutic vaccination
GB9812613D0 (en)	1998-08-12	Vaccine
PL346651A1 (en)	2002-02-25	Vaccine against sexually transmitted diseases
PL344519A1 (en)	2001-11-05	Vaccine
SI1117421T1 (en)	2004-12-31	Methods for therapeutic vaccination
GB9820956D0 (en)	1998-11-18	Vaccine
GB9821821D0 (en)	1998-12-02	Schistomiasis vaccine
GB9807805D0 (en)	1998-06-10	Vaccine
GB9802543D0 (en)	1998-04-01	Vaccine
GB9811954D0 (en)	1998-07-29	Vaccine
GB9812773D0 (en)	1998-08-12	Vaccine
GB9805962D0 (en)	1998-05-20	Vaccine
GB9807933D0 (en)	1998-06-10	Vaccine
GB9806765D0 (en)	1998-05-27	Vaccine
GB9805958D0 (en)	1998-05-20	Vaccine
GB9812228D0 (en)	1998-08-05	Vaccine
GB9805960D0 (en)	1998-05-20	Vaccine
GB9802544D0 (en)	1998-04-01	Vaccine
GB9822703D0 (en)	1998-12-09	Vaccine
GB9805961D0 (en)	1998-05-20	Vaccine
GB9828035D0 (en)	1999-02-10	Vaccine
GB9822709D0 (en)	1998-12-09	Vaccine
GB9822712D0 (en)	1998-12-09	Vaccine